Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA

References

• VakilNvan ZantenSVKahrilasPDentJJonesRGlobal Consensus GroupThe Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensusAm J Gastroenterol200610181900192016928254
   PubMed Web of Science ®Google Scholar
• KahrilasPJShaheenNJVaeziMFAmerican Gastroenterological AssociationAmerican Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux diseaseGastroenterology200813541383139118789939
   PubMed Web of Science ®Google Scholar
• El-SeragHBecherAJonesRSystematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studiesAliment Pharmacol Ther201032672073720662774
   PubMed Web of Science ®Google Scholar
• JonesRArmstrongDMalfertheinerPDucrottéPDoes the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey-based studyCurr Med Res Opin200622465766216684426
   PubMed Web of Science ®Google Scholar
• VakilNBjörckKDenisonHValidation of the Reflux Symptom Questionnaire electronic diary in partial responders to proton pump inhibitor therapyClin Transl Gastroenterol20123e723238029
   PubMed Web of Science ®Google Scholar
• ShawMJTalleyNJBeebeTJInitial validation of a diagnostic questionnaire for gastroesophageal reflux diseaseAm J Gastroenterol2001961525711197287
   PubMed Web of Science ®Google Scholar
• SnaithRPThe hospital anxiety and depression scaleHealth Qual Life Outcomes200312912914662
   PubMedGoogle Scholar
• WareJEJrSherbourneCDThe MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selectionMed Care19923064734831593914
   PubMed Web of Science ®Google Scholar
• RabinRde CharroFEQ-5D: a measure of health status from the EuroQol GroupAnn Med200133533734311491192
   PubMed Web of Science ®Google Scholar
• WahlqvistPMedinJKarlssonMResponsiveness to change and construct validity of the Work Productivity and Activity Impairment questionnaire for gastroesophageal reflux disease (WPAI:GERD) in Swedish patients [abstract]Value Health200912A60
   Web of Science ®Google Scholar
• 2009 Red Book: Pharmacy’s Fundamental ReferenceMontvale, NJThomson Reuters2009
   Google Scholar
• American Medical Association2009 National Physician Fee Schedule Relative Value FileChicago, ILAmerican Medical Association2009
   Google Scholar
• IngenixDRG Expert 2009: A Comprehensive Guidebook to the DRG Classification System25th edSalt Lake City, UTIngenix, Inc2009
   Google Scholar
• Bureau of Labor StatisticsEmployer costs for employee compensation [press release]Washington, DCBureau of Labor Statistics1282010
   Google Scholar
• ToghanianSJohnsonDAStålhammarNOZerbibFBurden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: a post hoc analysis of the 2007 national health and wellness surveyClin Drug Investig20113110703715
   Web of Science ®Google Scholar
• WahlqvistPKarlssonMJohnsonDCarlssonJBolgeSCWallanderMARelationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohortAliment Pharmacol Ther2008271096097018315585
   PubMed Web of Science ®Google Scholar
• ToghanianSWahlqvistPJohnsonDABolgeSCLiljasBThe burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohortsClin Drug Investig2010303167178
   Web of Science ®Google Scholar
• SpiegelBMThe burden of IBS: looking at metricsCurr Gastroenterol Rep200911426526919615301
   PubMedGoogle Scholar
• DeanBBAguilarDBarghoutVImpairment in work productivity and health-related quality of life in patients with IBSAm J Manag Care200511Suppl 1S17S2615926760
   PubMed Web of Science ®Google Scholar
• IsolauriJLuostarinenMIsolauriEReinikainenPViljakkaMKeyriläinenONatural course of gastroesophageal reflux disease: 17–22 year follow-up of 60 patientsAm J Gastroenterol199792137418995934
   PubMed Web of Science ®Google Scholar
• MalfertheinerPNoconMViethMEvolution of gastro-oesophageal reflux disease over 5 years under routine medical care – the ProGERD studyAliment Pharmacol Ther201235115416422070159
   PubMed Web of Science ®Google Scholar
• WuJCLaiLHChowDKWongGLSungJJChanFKConcomitant irritable bowel syndrome is associated with failure of step-down on- demand proton pump inhibitor treatment in patients with gastro-esophageal reflux diseaseNeurogastroenterol Motil201123215516021087355
   PubMed Web of Science ®Google Scholar
• SaitoYASchoenfeldPLockeGR3rdThe epidemiology of irritable bowel syndrome in North America: a systematic reviewAm J Gastroenterol20029781910191512190153
   PubMed Web of Science ®Google Scholar
• PaciniFCalabreseCCipollettaLBurden of illness in Italian patients with gastro-oesophageal reflux diseaseCurr Med Res Opin200521449550215899097
   PubMed Web of Science ®Google Scholar
• BierthoLSanjeevDSebajangHAntonyMAnvariMThe influence of psychological factors on the outcomes of laparoscopic Nissen fundoplicationAnn Surg Innov Res20071217411450
   PubMedGoogle Scholar
• PrasadMWahlqvistPShikiarRShihYCA review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspectivePharmacoeconomics200422422524414974873
   PubMed Web of Science ®Google Scholar
• WahlqvistPBrookRACampbellSMObjective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux diseaseJ Occup Environ Med2008501253118188078
   PubMed Web of Science ®Google Scholar
• GalindoGVassalleJMarcusSNTriadafilopoulosGMultimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapyDis Esophagus2012In press
   Web of Science ®Google Scholar
• MiyamotoMHarumaKTakeuchiKKuwabaraMFrequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapyJ Gastroenterol Hepatol200823574675118028348
   PubMed Web of Science ®Google Scholar
• FutagamiSIwakiriKShindoTThe prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptyingJ Gastroenterol201045441342119997942
   PubMed Web of Science ®Google Scholar
• MiyamotoMManabeNHarumaKEfficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategyIntern Med201049151469147620686276
   PubMed Web of Science ®Google Scholar